Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa & Mondher Toumi. (2019) Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results. Journal of Market Access & Health Policy 7:1.
Read now
Read now
Solomon Nuhoho, Abdallah Saad, Goretti Saumell, Daniel Ribes & Antoine C. El Khoury. (2018) Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates. Current Medical Research and Opinion 34:4, pages 601-611.
Read now
Read now
Junwen Zhou, Aurélie Millier & Mondher Toumi. (2018) Systematic review of pharmacoeconomic models for schizophrenia. Journal of Market Access & Health Policy 6:1.
Read now
Read now
Kruti Joshi, Xiaoyun Pan, Rosa Wang, Erru Yang & Carmela Benson. (2016) Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate. Current Medical Research and Opinion 32:11, pages 1873-1881.
Read now
Read now
Thomas R. Einarson, Susana Maia-Lopes, Pushpendra Goswami, Basil G. Bereza & Kristel Van Impe. (2016) Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal. Journal of Medical Economics 19:9, pages 913-921.
Read now
Read now
Thomas R. Einarson, Hanna Pudas, Pushpendra Goswami, Kristel van Impe & Basil G. Bereza. (2016) Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland. Journal of Medical Economics 19:2, pages 121-130.
Read now
Read now
Articles from other publishers (4)
Benjamin Kearns, Katy Cooper, Martin Orr, Munira Essat, Jean Hamilton & Anna Cantrell. (2022) The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model. Neuropsychiatric Disease and Treatment Volume 18, pages 1133-1143.
Crossref
Crossref
Huajie Jin, Paul Tappenden, Stewart Robinson, Evanthia Achilla, James H. MacCabe, David Aceituno & Sarah Byford. (2020) A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway. PharmacoEconomics 38:6, pages 537-555.
Crossref
Crossref
Flore Decuypere, Jan Sermon, Paul Geerts, Tom R. Denee, Cedric De Vos, Bart Malfait, Mark Lamotte & Cornelis L. Mulder. (2017) Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study. PLOS ONE 12:6, pages e0179049.
Crossref
Crossref
Mônica Kayo & Denise Razzouk. 2017. Mental Health Economics. Mental Health Economics
313
322
.